68Ga-grazytracer PET for noninvasive assessment of response to immunotherapy in solid tumors and lymphomas: a phase 1/2 clinical trialNATURE COMMUNICATIONSIF15.72024-10-100OAAI
68Ga-DOTA-FAPI-04 PET/CT in the Detection of Thoracic SMARCA4-Deficient Undifferentiated TumorCLINICAL NUCLEAR MEDICINEIF9.62023-10-162PRE
Superiority of [68Ga]Ga-DOTA-FAPI-04 PET/CT to [18F]FDG PET/CT in the evaluation of thymic epithelial tumoursEuropean Journal of Nuclear Medicine and Molecular ImagingIF7.62023-06-151PRE
Noninvasive interrogation of CD8+T cell effector function for monitoring early tumor responses to immunotherapyJOURNAL OF CLINICAL INVESTIGATIONIF13.62022-08-1520OAAI